发明申请
US20110166191A1 3-(2-amino-ethyl)-5-(3-cyclohexyl-propylidene)-thiazolidine-2,4-dione and its derivatives as multiple signaling pathway inhibitors and for the treatment of cancer 审中-公开
3-(2-氨基 - 乙基)-5-(3-环己基 - 亚丙基) - 噻唑烷-2,4-二酮及其衍生物作为多重信号通路抑制剂和治疗癌症

  • 专利标题: 3-(2-amino-ethyl)-5-(3-cyclohexyl-propylidene)-thiazolidine-2,4-dione and its derivatives as multiple signaling pathway inhibitors and for the treatment of cancer
  • 专利标题(中): 3-(2-氨基 - 乙基)-5-(3-环己基 - 亚丙基) - 噻唑烷-2,4-二酮及其衍生物作为多重信号通路抑制剂和治疗癌症
  • 申请号: US12984825
    申请日: 2011-01-05
  • 公开(公告)号: US20110166191A1
    公开(公告)日: 2011-07-07
  • 发明人: Shijun ZhangTai Liang Guo
  • 申请人: Shijun ZhangTai Liang Guo
  • 主分类号: A61K31/426
  • IPC分类号: A61K31/426 C07D277/34 A61P35/00 C12N5/02 C12N9/99
3-(2-amino-ethyl)-5-(3-cyclohexyl-propylidene)-thiazolidine-2,4-dione and its derivatives as multiple signaling pathway inhibitors and for the treatment of cancer
摘要:
3-(2-amino-ethyl)-5-(3-cyclohexyl-propylidene)-thiazolidine-2,4-dione and derivatives thereof are provided for use as dual inhibitors of the Raf/MEK/ERK and PI3K/Akt pathways and for use in the treatment of cancer.
信息查询
0/0